Rigel Pharmaceuticals (RIGL) Cash from Operations (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -87.60% |
| Dec 31, 2025 | -8.53% |
| Sep 30, 2025 | -21.31% |
| Jun 30, 2025 | 3,519.60% |
| Mar 31, 2025 | -106.16% |
| Dec 31, 2024 | -33.10% |
| Sep 30, 2024 | 7,078.48% |
| Jun 30, 2024 | 106.02% |
| Mar 31, 2024 | 19.66% |
| Dec 31, 2023 | -359.16% |
| Sep 30, 2023 | -122.92% |
| Jun 30, 2023 | 245.56% |
| Mar 31, 2023 | 81.40% |
| Dec 31, 2022 | -64.72% |
| Sep 30, 2022 | -3.02% |
| Jun 30, 2022 | 49.64% |
| Mar 31, 2022 | -34.32% |
| Dec 31, 2021 | -85.35% |
| Sep 30, 2021 | -118.65% |
| Jun 30, 2021 | 376.70% |
| Mar 31, 2021 | -28.15% |
| Dec 31, 2020 | 20.07% |
| Sep 30, 2020 | -38.78% |
| Jun 30, 2020 | -353.86% |
| Mar 31, 2020 | 67.94% |
| Dec 31, 2019 | 34.10% |
| Sep 30, 2019 | 12.07% |
| Jun 30, 2019 | -2,826.36% |
| Mar 31, 2019 | -104.89% |
| Dec 31, 2018 | 157.98% |
| Sep 30, 2018 | 25.61% |
| Jun 30, 2018 | -15.39% |
| Mar 31, 2018 | -18.66% |
| Dec 31, 2017 | -11.95% |
| Sep 30, 2017 | 9.55% |
| Jun 30, 2017 | 6.22% |
| Mar 31, 2017 | -66.58% |
| Dec 31, 2016 | 44.78% |
| Sep 30, 2016 | -22.44% |
| Jun 30, 2016 | 17.78% |
| Mar 31, 2016 | -62.50% |
| Dec 31, 2015 | -45.89% |
| Sep 30, 2015 | 47.88% |
| Jun 30, 2015 | -200.88% |
| Mar 31, 2015 | 219.88% |
| Dec 31, 2014 | 18.35% |
| Sep 30, 2014 | 7.86% |
| Jun 30, 2014 | -21.40% |
| Mar 31, 2014 | 13.09% |
| Dec 31, 2013 | 8.88% |
| Sep 30, 2013 | 2.71% |
| Jun 30, 2013 | 15.09% |
| Mar 31, 2013 | -16.41% |
| Dec 31, 2012 | -9.92% |
| Sep 30, 2012 | 5.38% |
| Jun 30, 2012 | 10.88% |
| Mar 31, 2012 | -24.76% |
| Dec 31, 2011 | -45.81% |
| Sep 30, 2011 | 25.47% |
| Jun 30, 2011 | 17.33% |
| Mar 31, 2011 | -302.21% |
| Dec 31, 2010 | 154.02% |